4D Molecular Therapeutics (FDMT) Q4 2025 Earnings

10NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.01
-0.92
-0.82
-0.73

Details

Expected EPS
-0.9826
Actual EPS
-1.01
Surprise EPS
-0.03
Surprise Percent
+2.79%

Description

4D Molecular Therapeutics (FDMT) has reported earnings of -1.01 per share for Q4 2025.

0 Comments

Share your thoughts